ArticleJournal of orthopaedic case reports2026
Prediction of Arterial Extravasation in Pelvic Fracture Patient with Stable Hemodynamics Using Coagulation Biomarkers: A Prospective Observational Cohort Study.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intoduction: In patients who are hemodynamically stable, thrombosis indicators including fibrin degradation products (FDP), D-dimer, prothrombin time-international normalized ratio (PT-INR), along with the FDP-to-fibrinogen proportion may be capable determine artery escape as well as allow for timely treatment. Objectives: The objective of the study was to explore the possible use of anticoagulation biomarkers as additional or additional tests for diagnosis to computed tomography (CT) by evaluating their prediction accuracy for vascular invasion among people with pelvic fractures who have stable hemodynamics. Materials and Methods: Over the course of 20 months, prospective observational cohort research was carried out at the LLR Hospital, GSVM Medical College, Kanpur. We excluded individuals with instability health or significant concomitant injuries and only considered those who were adults (>18 years old) with broken pelvis with stable hemodynamics. Following CT angiography, patients were split into a couple of categories: Extravasation (Group 1, n = 24) along with non-extravasation (Group 2, n = 16). FDP, D-dimer, (PT), active partial thromboplastin time, platelet count, fibrinogen, and the FDP-to-fibrinogen ratio were all measured in blood draws obtained during admittance. To evaluate the predictive abilities of biomarkers, statistical studies were conducted using receiver operating characteristic (ROC) curves, Chi-square tests, along with t-tests. Results: The Extravasation group exhibited significantly higher FDP (14.31 µg/mL vs. 5.52 µg/mL, P < 0.001), D-dimer (789.17 ng/mL vs. 253.38 ng/mL, P < 0.001), PT (16.92 s vs. 13.27 s, P < 0.0001), INR (1.46 vs. 1.16, P = 0.012), and FDP-to-fibrinogen ratio (0.0219 vs. 0.0129, P = 0.0035) compared to the non-extravasation group. The FDP-to-fibrinogen ratio demonstrated the highest area under the ROC curve (area under the curve [AUC] = 0.92), followed by FDP (AUC = 0.85) and D-dimer (AUC = 0.83). Patients with elevated biomarkers were more likely to require angiographic embolization (P < 0.05). Injury Severity Scores were higher in the Extravasation group (mean 17.5 vs. 10.5, P < 0.05). Mortality was low (2.5%, one case in Group 1). Conclusion: Coagulation biomarkers, particularly the FDP-to-fibrinogen ratio, FDP, and D-dimer, are robust predictors of arterial extravasation in hemodynamically stable pelvic fracture patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.